Abstract-Secondary uses of medical data are not directly related to the delivery of healthcare to an individual and the provision of privacy within this context is increasingly challenging. This paper integrates theoretical and empirical research regarding privacy and proposes a privacy framework to support secondary use of medical data. Theoretical aspects consider two contemporary privacy theories and empirical aspects incorporate consumer survey results to propose a privacy framework for secondary use of medical data. This research is part of a larger study undertaken within the post-positivist and interpretive paradigms utilizing mixed methods. The proposed privacy framework engages healthcare consumers in decision making regarding the secondary use of their data. privacy; data management; secondary use medical data; information privacy theory
INTRODUCTION
Traditionally the privacy of medical patients personal information is protected through interpretations of the 'limited access' theory of privacy which in many cases was instantiated through to secure storage of physical paper charts. With the change in medium for capture and storage of personal information from paper based to electronic medium the 'limited access' approach to privacy is under pressure due to the ease with which electronic information can be exchanged. Secondary uses of medical data are those not directly related to the delivery of healthcare to an individual [1] . Contemporary privacy theories may better address privacy matters in the secondary use of medical data context. This paper provides : an overview of secondary use of medical data and associated privacy challenges; introduces the contemporary privacy theory of Nissenbaum [2, 3] and Tavani and Moor [4] [5] [6] ; gives an overview of an Australian and Canadian consumer survey exploring these issues and; presents a privacy framework. The contribution here relates to the integration of theoretical and empirical research involving privacy and proposal of a privacy framework to aid in engaging consumers regarding secondary use of their medical data.
II. THE SECONDARY USE OF MEDICAL DATA CONTEXT

A. Overview
The context of secondary use of medical data is one where privacy issues pose challenges with some stakeholders feeling privacy matters are too restrictive [7] [8] [9] [10] and others calling for enhanced consumer privacy and consent affordances [11] [12] [13] .
Diverse stakeholders seek access to medical data for secondary purposes. These include those with utilitarian objectives and those with more commercial goals. For example medical researchers require data to improve societal knowledge of healthcare and in contrast commercial stakeholders seek access to medical data to enhance profitability of organizations. There is a growing realization of the commercial value of healthcare data [14] . It is acknowledged that the boundary between utilitarian research and commercial purposes may be ill defined. The consumer survey results considered here indicate awareness amongst consumers of the diverse stakeholders and motivations that exist in the secondary use of medical data domain. Meaningful engagement with healthcare consumers is of growing importance in this context [12, [15] [16] [17] and an improved approach to privacy would enable progress.
B. Anonymised data
The widespread use of anonymised data in secondary use rests comfortably with early concepts of privacy which focused on ensuring it was not possible to identify an individual. Contemporary theories of privacy are more nuanced. A simple scenario illustrates the growing inadequacy of anonymisation/de-identification. As healthcare consumers' medical data is anonymised and then aggregated with similar consumer data, over a period of time patterns can emerge across the datasets. This can result in the emergence of intelligence that was unrecognized when dealing with a single consumer health record. In the context of health research this outcome would likely be viewed positively. In a personal insurance context, the use of seemingly innocuous anonymised data takes on a whole new dimension as consumer lifestyle, physiological and genetic factors are incorporated into predictive analytics models. Business intelligence models developed using aggregated, anonymised data can deliver far more power than may have been imagined with the single anonymous health record.
The qualitative consumer survey data gathered by the Australian and Canadian surveys indicates that consumers appreciate the potential, positive results from anonymised data use. Simultaneously many respondents were aware of the negative impact for secondary uses that may not be in the best interest of themselves or their families.
III. CONTEMPORARY PRIVACY THEORY
A. Overview
Privacy is a difficult concept to define with varying perspectives provided across multiple disciplines including law [18, 19] , philosophy [20, 21] and socio-technical systems [4, 6, 22, 23] . Privacy considers the protection of individuals and broad classifications of privacy situations and may include theories such as control or limited access. Recent publications on information privacy theory attempt to provide contemporary conceptualizations of privacy [24] [25] [26] . There are few publications exploring the application of these theories to the 'real-world' [27, 28] . The secondary use of medical data domain offers a challenging context in which to explore the pragmatic application of information privacy theory. The theoretical work of Nissenbaum, Tavani and Moor were selected for this study as they are developed in some detail, are relatively comprehensive and provide a useful platform to support the engagement of consumers in privacy aspects of secondary use of their medical data. In addition, the selected privacy frameworks are attempting to move beyond traditional limited access and control conceptualizations of privacy and hence may afford opportunities for progress. The research described here is part of a larger study undertaken within postpositivist and interpretive paradigms utilizing mixed methods with a concurrent triangulation design.
B. Privacy as contextual integrity
Nissenbaum attempts to shift the privacy debate beyond 'control' or 'limitation/constraint' by noting the value of both and encouraging a move beyond these early privacy theories by acknowledging a resolution of the struggle for dominance between these privacy concepts may not be possible.
Nissenbaum proposed 'privacy as contextual integrity' as a conception of information privacy where informational norms govern activities within particular contexts. There are four key parameters used to characterize context relative information norms: (1) contexts (2) actors (3) attributes and (4) transmission principles.
• • Actors include senders and receivers of information and the information subjects.
• Attributes, or information types, co-evolve with contexts and are more nuanced than public or private attributes.
• Transmission principles control the flow of information within a context.
C. Hybrid privacy theory
Tavani and Moor have proposed a hybrid privacy theory in a series of both individual and co-authored publications [4, 23, 29] . These researchers sought to identify the fundamental, essential components necessary in a privacy theory. One outcome of their research is a tripartite model to describe a sufficient theory for privacy: The privacy theory building research undertaken by Tavani and Moor has resulted in a context sensitive, hybrid Restricted Access/Limited Control (RALC) theory. In RALC individual control is important in both the justification and management of privacy and also important to restricted access in terms of the concept of privacy. Three key controls are suggested: individual (choice, consent and correction), restricted access and external controls (privacy policy and legislation).
A strength of Moor and Tavani's work is that they tackled the fundamental, important matter of developing a privacy theory rather than devising particular justifications or recommendations for management of privacy that are suitable for particular contexts. Tavani was particularly determined to take a holistic view with the aim of providing a theory that can be effective in a wide range of contexts
D. Australian and Canadian consumer survey
To further explore the viability of combining and applying contemporary privacy theories in the secondary use of medical data context, a consumer survey was undertaken in Australia and Canada to investigate the following research question: Does the RALC and framework for contextual integrity offer privacy concepts that can: (1) be applied in the secondary use of medical data context and (2) gain support from interested consumers?
The consumer surveys were conducted in 2010-2011 using a hard copy, self-administered survey which included thirty attitudinal questions with responses gathered on a five point Likert scale. The survey constructs explored Tavani and Moor's concept, justification and management of privacy as they pertain to the secondary use domain. Two open ended questions provided an opportunity to capture qualitative data from respondents. In total 1,573 responses were received from citizens in Australia and Canada. Survey results indicated diverse concerns and expectations regarding privacy with statistically significant results across gender, highest education level, age and healthcare workers, these survey results are reported in more detail elsewhere [30] [31] [32] . The internal reliability of the privacy concept, privacy justification and privacy management constructs was evaluated using Cronbach alpha and validity within the exploratory range was achieved for each construct.
The consumer survey results were useful in informing four key parameters of Nissenbaum's 'privacy as contextual integrity' framework as appropriate for this specific secondary use of medical data context. In addition, the survey results provided clarity on consumer expectations in terms of Tavani and Moor's concept, justification and management of privacy and key controls for individuals, restricted access and external policy and regulation controls. The next section introduces the development of the privacy framework.
IV. PRIVACY FRAMEWORK
This section describes: the application of the selected contemporary privacy theories; incorporation of conceptual understandings of consumer expectations and; the proposed conceptual privacy framework. The focus here is on the clarification of the conceptual privacy framework which must be determined prior to any attempts at physical implementation of an information system solution.
A. Including privacy as contextual integrity
Elements of the "privacy as contextual integrity" framework are considered below.
Context
The context for the proposed Privacy Framework is the secondary use of medical data in Australia and Canada where diverse stakeholders seeking access to consumer medical data.
Actors
In the secondary use of medical data context the senders of information are most likely to be healthcare providers. In this context the receivers include: medical researchers; health service researchers; commercial data 'harvesting' organizations; Government organizations; Insurance sector stakeholders and other stakeholders we cannot yet anticipate. The subjects of the information are patients/consumers.
Attributes (Information Types)
The data attributes (Information Types) in this context include a diverse range of physiological measurements, diagnoses, family history, medication history, mental health attributes, diseases and conditions experienced by the consumers etc. The data types are equally diverse including but not limited to: images, text, numeric, encoded physiological data, unstructured, narrative text, data streams and multi-media entries [33] . The sensitivity levels on each attribute vary with the most sensitive being mental and sexual health.
Transmission Principles
The Transmission Principles describe the context specific terms and conditions under which information may flow between actors. Consumer specific expectations regarding these terms and conditions is derived from the Australian and Canadian survey results and prior literature. The consumer survey revealed that respondents would like to be consulted regarding the terms and conditions surrounding information flows. Statistically significant differences were found between women and men on the privacy management construct with qualitative comments indicating women sought more control over the terms and conditions under which their data could be provided to stakeholders for secondary use.
The inclusion of the consumer expectations in defining the transmission principles is one of the most forward looking aspects of the privacy framework as previously consumers were largely not empowered to participate in determining such transmission principles, particularly for anonymized data.
Frequently human research ethics committees and/or health sector leaders and clinicians make decisions regarding acceptable terms and conditions surrounding flow of consumer medical information. Inclusion of the consumers as actors determining the terms and conditions of data flows is an important aspect of the application of Nissenbaum's contextual-integrity framework and speaks directly to the need to more actively engage consumers in decision making regarding secondary data use [12, 15] .
B. Including privacy concept, justification and management
Exploring the application of Tavani and Moor's concept, justification and management of privacy through the consumer surveys led to an enhanced appreciation of the diversity of views amongst consumers regarding their privacy resulting in an interest and capacity conceptualization as presented in Figure 1 . The consumer survey results indicate there are varying levels of interest amongst respondents regarding matters pertaining to secondary use of medical data. The consumers who responded to the Australian and Canadian surveys, for example, may represent the more engaged community members given that they voluntarily responded to the survey. There are likely to be other members of the community who have no interest in considering secondary use matters. There are also citizens who place enormous value on their personal privacy and their engagement in secondary use may vary from removing themselves entirely to looking for opportunities for maximum influence and authority over the secondary use of their data.
There are also varying individual capacities to engage on secondary matters. For example citizens living with severe mental health issues, minors and dementia suffering or very elderly citizens may not have the capacity to engage on secondary use and privacy matters.
Four levels of engagement amongst consumers are depicted in Figure 1 : Conceptualizing consumer engagement. The consumer engagement Levels 0-3 assist in grouping consumers into segments that have differing expectations regarding privacy and secondary use of their medical data. The intention of the Privacy Framework is to empower consumers in making choices pertaining to privacy and secondary use of data. Zones have been blocked out in Figure  1 however no metrics have been applied as it is not possible, with available knowledge, to predict the end of one grouping and the beginning of the next. White buffer zones have been included in the diagram, lying between each of the zones or groups to emphasize that the boundaries of each group are ill defined. This figure assists in conceptualizing the varying levels of concurrent interest and capacity to engage in secondary data use and associated privacy matters amongst consumers and is informed by survey outcomes.
There are infinite combinations of citizens with varying levels of interest and capacity to engage in secondary use of medical data matters. If an individual has low or minimal capacity to engage in decision making regarding secondary use of their medical data it is irrelevant how much interest they may show in secondary use matters as they are incapable of making necessary decisions. There are other citizens who have sufficient capacity to engage in secondary matters but low levels of interest. There are comments in the Australian and Canadian consumer surveys from citizens who would fit this group. Much of this speaks to Tavani and Moor's individual (choice, consent, correction) key theory element and aspects of privacy concept, justification and management.
Level 0 is similar to the current operation of HREC where committee members make determinations about the release of consumer medical data and may or may not request that researchers obtain informed consent from their research subjects. It is possible at Level 0 engagement that HRECs may authorize the release of consumer data without any regard to the consumers' preference. In the Privacy Framework described here if the consumer has not provided any secondary use directives the level of engagement is defaulted to Level 0. This situation may not satisfy consumers with concerns regarding privacy and such citizens should be encouraged to move to Level 1 and record a "No secondary use" directive. Alternatively they could move to Level 3 engagement where they can achieve greater autonomy and control.
Level 1 provides consumers with an opportunity to give high level guidance on the use of their data. The intent is for this not to be project specific consent but rather a broad 'yes' or 'no' to the use of an individual's data for any kind of secondary purpose. If a consumer registers a "No" at this Level of engagement their personal medical data should not be used for any secondary purpose. If consumers want to give project specific consent they need to move to Level 2 engagement. At Level 1 consumers may refine the "Yes" response by providing broad direction e.g. available for commercial or non-commercial secondary use. The provision of Level 1 engagement could also expedite the availability of data for secondary use as consideration of data access issues by HREC may not be necessary if capable consumers have provided informed consent through the Privacy Framework at Level 1. This would be of benefit to many researchers who report delays in approval and lack of consistency between HRECs. The role of HREC would be to provide approval for the overall study but to limit the instructions regarding data issues to the secondary directives provided by the consumers.
Level 2 enables consumers to provide Level 1 direction plus further refinements regarding consent. Consumers may choose to provide consent per study or the consumer may provide a pre-approval for secondary uses that meet specific requirements. The latter approach would reduce the number of consumer contacts required to seek consent and hence expedite data availability.
It is important to reflect on the hierarchical nature of the Levels of engagement. If at Level 1 a consumer indicated that they were not interested in having their data used for commercial secondary purposes it would not be possible, within the operation of this privacy framework, for consumers to be asked to provide Level 2 study specific consent for a commercial secondary study. The only consumers who should be approached for such a study are those who, at Level 1, indicated 'Yes' they support secondary use of a commercial nature and at Level 2 indicated a wish to give study specific consent. 
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The consumer survey qualitative data indicated that some consumers would not be satisfied with a single consent option and would prefer to provide consent for each study. In contrast other survey respondents were satisfied with the notion of a single, re-usable consent. Level 2 also provides consumers with an opportunity to select specific secondary uses they wish to support such as breast cancer, depression, renal disease research.
Level 3 enables consumers to provide Level 2 (which includes Level1) direction plus further refinement to take the engagement to the finest granularity available through the privacy framework. Level 3 includes directions regarding feedback on secondary use of medical data. Consumers may expect to be informed not only regarding studies that have used their data but also the outcomes from the studies. This type of feedback was well received by some Australian survey respondents who had participated in secondary use studies and they stated this encouraged them to continue participating. Level 3 engagement also provides an opportunity to 'put their hands up' and allow for identification and availability for further contact. The gathering of fully informed consent is a challenge in the secondary use of data, and offering levels 0-3 of engagement works towards improved understanding amongst consumers. This privacy framework does not propose that consumers consider each attribute of their electronic health record(s) and decide if individual data elements should be available for secondary use. This would be unmanageable due to the complexity involved in specification and maintenance of consumer views regarding the details of their electronic health record. The concept of the engagement levels within the privacy framework has captured many of the aspects of contemporary privacy theory previously described. Figure 2 is a cube shaped conceptualization of the combined contemporary privacy theory elements with increasing consumer engagement through Levels 0-3. The privacy framework elements include the context, actors, data attributes and default sensitivity settings, terms for data flow, conditions for data flow and increasing levels of engagement. The context is the overall 'cap' on the cube and the data subjects, senders and receivers are embedded within the cube. A narrow, vertical 'slice' through the conceptual model would include all the privacy fundamentals. A larger vertical 'slice' captures the same privacy elements but offers more depth to the associated consumer privacy engagement.
C. Concept cube
Moving from this logical, conceptual model towards a physical implementation would result in the consumers Privacy Framework directives being permanently stored with their electronic medical record. Ongoing research is exploring the development of an information system solution supporting the operation of the privacy framework in parallel with the electronic medical records.
V. CONCLUSION
This paper has illustrated the very pragmatic use of contemporary privacy theory, moving forward the complex privacy issues operating in the secondary use of medical data context. The conflicting utilitarian and commercial goals amongst stakeholders in the secondary use of medical data context call for improved privacy concepts, justifications and management. The actors, attributes, terms and conditions elements of the 'privacy as contextual-integrity' framework combine with the privacy concept, privacy justification and privacy management elements of Tavani and Moor's privacy theory to deliver a solid privacy foundation for the engagement of healthcare consumers in secondary use of their medical data. 
